Log in or Sign up for Free to view tailored content for your specialty!
Hidradenitis Suppurativa News
FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa
The FDA has approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults, UCB announced in a press release.
Genetic variants for hidradenitis suppurativa linked to cardiovascular disease, diabetes
Genetic variants found in hidradenitis suppurativa may be correlated to genetic variants in coronary artery disease and diabetes, according to a study.
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.
Log in or Sign up for Free to view tailored content for your specialty!
First patient dosed in phase 2 trial evaluating AVTX-009 for hidradenitis suppurativa
Researchers have dosed the first patient in a phase 2 trial evaluating AVTX-009 for the treatment of hidradenitis suppurativa, Avalo Therapeutics announced in a press release.
Top news of September: Sunscreen, endocrine-disrupting chemicals, Ozempic, more
The FDA’s inaction approving sunscreen ingredients as well as studies about endocrine-disrupting chemicals in personal care products and Ozempic’s impact on hidradenitis suppurativa led Healio Dermatology’s most-read articles in September.
Bimzelx effective, well-tolerated in hidradenitis suppurativa up to 2 years
Bimzelx maintained improvements in hidradenitis suppurativa for up to 2 years, according to an oral presentation on two phase 3 studies and one extension trial at the European Academy of Dermatology and Venerology Congress.
Semaglutide improves hidradenitis suppurativa outcomes
Semaglutide was shown to reduce hidradenitis suppurativa flares in patients with obesity, according to a study presented at the European Academy of Dermatology and Venereology meeting.
Catch up with top Healio Dermatology news from August
Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.
IRAK4 overexpressed in hidradenitis suppurativa, could be downregulated by degrader
Researchers confirmed that the interleukin-1 receptor-associated kinase 4 protein plays a role in the pathogenesis of hidradenitis suppurativa and that a degrader treatment may impact the disease, according to a study.
Smoking cessation associated with reduced hidradenitis suppurativa risk
Quitting smoking and maintaining smoking cessation was associated with a reduced risk for developing hidradenitis suppurativa, according to a study.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read